About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 277 record(s)
Req # A-2020-09098
Copies of all records discussing the impacts of the regulatory changes to the PMPRB from August 2019 until August 2020. Copies of all correspondence from all pharmaceutical companies expressing their concerns with the changes and any responses back to these companies. Copies of all correspondence from all advocating groups expressing concerns with the changes and any responses back to these groups. Copies of all correspondence between departmental staff discussing the impacts of the regulatory changes to the PMPRB. Copies of all records discussing the impacts of the PMPRB changes on individuals living with rare diseases. Copies of all correspondence from Vertex Pharmaceuticals relating to Kalydeco, Orkambi, Symdeko, and Trikafta. Copies of all correspondence between government officials (Prime Minister, Ministers, all members of parliament, constituency staff, deputies, assistant deputies, directors, managers, supervisors, staff, and any other employee of the Government of Canada relating to the PMPRB regulatory changes. Copies of all presentations relating to the PMPRB regulatory changes.Organization: Patented Medicine Prices Review Board Canada
September 2020
Req # A-2020-01436
Copies of reports, discussions, briefings, memos and decisions related to the introductory price review for erenumab (Aimovig) from January 2018 to February 2020.Organization: Patented Medicine Prices Review Board Canada
August 2020
Req # A-2020-04137
Copies of the PMPRB documentation related to the scientific review and pricing review of erenumab (Aimovig) from January 2018 to February 2020.Organization: Patented Medicine Prices Review Board Canada
August 2020
Req # A-2020-00052
I would like to obtain the following documents: The contract for the loan of *** million and recently granted by EDC to a customer of EDC. Correspondence concerning this loan between EDC and its customer and or by Innovation Science and Economic Development Canada and or the Ministry of the Privy Council including the ministers' offices.Organization: Export Development Canada
June 2020
Req # A-2020-00029
By this letter I am requesting access to all documentation with Export Development Canada dealing with the following companies and persons:Organization: Export Development Canada
March 2020
Req # A-2020-00008
Please provide a copy of the original loan agreement between Export Development Canada and the loan recipient, which was subsequently mentioned as a write-off of $196, 010, 248 from Export Development Canada's Canada Account, as mentioned in the most recent Public Accounts.Organization: Export Development Canada
February 2020
Req # A-2020-00009
Please provide all records, files, and documents, including electronic correspondence and data, sent/rec by officials at the DG, ADM or DM level regarding the write-off of $196, 010, 248 from Export Development Canada's Canada Account, as mentioned in the most recent Public Accounts, generated from the start of 2018 to January 23rd, 2020.Organization: Export Development Canada
February 2020